US EditionPublished • loading... • Updated
Purdue Researchers Discover New Therapeutic Target for Triple-Negative Breast Cancer
PACT protein suppresses RNA-activated protein kinase, offering a new targeted therapy for triple-negative breast cancer, which currently lacks specific treatments, researchers said.
Summary by News Medical
2 Articles
2 Articles
New therapeutic target for breast cancer involves double-stranded RNA-binding proteins
A Purdue University team has discovered a new therapeutic target for triple-negative breast cancer. The research, led by Kyle Cottrell, an assistant professor of biochemistry, spotlights double-stranded ribonucleic acid (dsRNA)-binding proteins.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center2Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
